---
title: "NYMOX PHARMACEUTICAL CORPORATION (BAHAMAS) LTD. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3
json: https://whiteintel.dev/api/public/dossier/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3
identifier: icij:icijol-20173890
jurisdiction: BS
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# NYMOX PHARMACEUTICAL CORPORATION (BAHAMAS) LTD.

**Type:** Company  
**Jurisdiction:** [BS](https://whiteintel.dev/jurisdictions/bs)  
**Identifier:** `icij:icijol-20173890`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **1-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Provenance

- ICIJ Offshore Leaks — https://offshoreleaks.icij.org/nodes/20173890

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NYMOX PHARMACEUTICAL CORPORATION (BAHAMAS) LTD.**. Human view: https://whiteintel.dev/entity/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3 · Structured JSON: https://whiteintel.dev/api/public/dossier/2d2fa2a7-4d3a-5cbf-9d1f-089745789bf3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._